Pharmacological treatment for familial amyloid polyneuropathy

Review (4 RCTs, n=655) found no studies directly comparing disease‐modifying pharmacological treatments. However, results from placebo‐controlled trials indicate tafamidis, diflunisal, patisiran and inotersen may be beneficial treatments, but further investigations are needed.

Source:

Cochrane Database of Systematic Reviews